Prunell Giselle F, Arboleda Valerie A, Troy Carol M
Department of Pathology, Taub Institute for the Study of Alzheimer's Disease and the Aging Brain, Columbia University College of Physicians and Surgeons, 630 W 168 ST, New York, NY 10032, USA.
Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):51-61. doi: 10.2174/1568007053005082.
Cerebral ischemia is one of the major causes of morbidity and mortality in the Western world. Despite extensive research, adequate therapies are still elusive. Neuronal degeneration and death are hallmarks of stroke/ischemia. Understanding how the death machinery executes neuronal death in ischemia will provide therapeutic targets. Key to the death machinery are caspases: the family of cell death proteases. While much data has been published regarding caspase involvement in models of ischemia, the pathways have not been thoroughly defined. The specification of the caspases critical for death has been hampered by the use of non-specific reagents. Thus many conclusions about specificity are unwarranted. In this review we discuss how caspases can be measured and review the existing knowledge of the roles of specific caspases in ischemia. We also discuss approaches to determining the molecules that execute ischemic death.
脑缺血是西方世界发病和死亡的主要原因之一。尽管进行了广泛研究,但仍难以找到充分的治疗方法。神经元变性和死亡是中风/缺血的标志。了解死亡机制如何在缺血中导致神经元死亡将为治疗提供靶点。死亡机制的关键是半胱天冬酶:细胞死亡蛋白酶家族。虽然已经发表了许多关于半胱天冬酶参与缺血模型的数据,但相关途径尚未得到充分界定。由于使用了非特异性试剂,对导致死亡至关重要的半胱天冬酶的具体情况一直难以明确。因此,许多关于特异性的结论是没有根据的。在本综述中,我们讨论了如何检测半胱天冬酶,并回顾了关于特定半胱天冬酶在缺血中作用的现有知识。我们还讨论了确定执行缺血性死亡的分子的方法。